These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 14654101

  • 1. Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
    Roman S, Badia A, Camps P, Clos MV.
    Neuropharmacology; 2004 Jan; 46(1):95-102. PubMed ID: 14654101
    [Abstract] [Full Text] [Related]

  • 2. Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
    Roman S, Badia A, Camps P, Muñoz-Torrero D, Clos MV.
    Brain Res; 2005 Nov 09; 1061(2):73-9. PubMed ID: 16248990
    [Abstract] [Full Text] [Related]

  • 3. Interaction of a new potent anticholinesterasic compound (+/-)huprine X with muscarinic receptors in rat brain.
    Roman S, Vivas NM, Badia A, Clos MV.
    Neurosci Lett; 2002 Jun 07; 325(2):103-6. PubMed ID: 12044632
    [Abstract] [Full Text] [Related]

  • 4. The pharmacology of novel acetylcholinesterase inhibitors, (+/-)-huprines Y and X, on the Torpedo electric organ.
    Ros E, Aleu J, Gómez de Aranda I, Muñoz-Torrero D, Camps P, Badia A, Marsal J, Solsona C.
    Eur J Pharmacol; 2001 Jun 08; 421(2):77-84. PubMed ID: 11399262
    [Abstract] [Full Text] [Related]

  • 5. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB, Reuben M.
    Br J Pharmacol; 1996 Feb 08; 117(4):595-606. PubMed ID: 8646402
    [Abstract] [Full Text] [Related]

  • 6. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function.
    Marchi M, Raiteri M.
    J Neurochem; 1996 Nov 08; 67(5):1974-81. PubMed ID: 8863503
    [Abstract] [Full Text] [Related]

  • 7. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J.
    Synapse; 2007 Jan 08; 61(1):29-36. PubMed ID: 17068780
    [Abstract] [Full Text] [Related]

  • 8. Nicotinic autoreceptor function in rat brain during maturation and aging: possible differential sensitivity to organophosphorus anticholinesterases.
    Wu YJ, Harp P, Yan XR, Pope CN.
    Chem Biol Interact; 2003 Jan 06; 142(3):255-68. PubMed ID: 12453664
    [Abstract] [Full Text] [Related]

  • 9. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
    Zwart R, van Kleef RG, Gotti C, Smulders CJ, Vijverberg HP.
    J Neurochem; 2000 Dec 06; 75(6):2492-500. PubMed ID: 11080202
    [Abstract] [Full Text] [Related]

  • 10. Nicotinic receptors modulating ACh release in rat cortical synaptosomes: role of Ca2+ ions in their function and desensitization.
    Marchi M, Lupinacci M, Bernero E, Bergaglia F, Raiteri M.
    Neurochem Int; 1999 Apr 06; 34(4):319-28. PubMed ID: 10372918
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC, Jeltsch H, Neufang B, Lauth D, Szabo B, Jackisch R.
    Brain Res; 1995 Dec 18; 704(2):153-66. PubMed ID: 8788910
    [Abstract] [Full Text] [Related]

  • 12. Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals.
    Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M.
    J Neurochem; 2002 Mar 18; 80(6):1071-8. PubMed ID: 11953457
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.
    Wilkie GI, Hutson P, Sullivan JP, Wonnacott S.
    Neurochem Res; 1996 Sep 18; 21(9):1141-8. PubMed ID: 8897478
    [Abstract] [Full Text] [Related]

  • 14. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA, Heimala K, Wonnacott S.
    Mol Pharmacol; 2003 Nov 18; 64(5):1217-26. PubMed ID: 14573772
    [Abstract] [Full Text] [Related]

  • 15. Effects of (+/-)-huprine Y and (+/-)-huprine Z, two new anticholinesterasic drugs, on muscarinic receptors.
    Alcalá MM, Maderuelo A, Vivas NM, Camps P, Muñoz-Torrero D, Clos MV, Badia A.
    Neurosci Lett; 2005 May 06; 379(2):106-9. PubMed ID: 15823425
    [Abstract] [Full Text] [Related]

  • 16. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
    Camps P, Cusack B, Mallender WD, El Achab RE, Morral J, Muñoz-Torrero D, Rosenberry TL.
    Mol Pharmacol; 2000 Feb 06; 57(2):409-17. PubMed ID: 10648652
    [Abstract] [Full Text] [Related]

  • 17. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B, Ivanov VB, Wiker C, Svensson TH.
    Neuropsychopharmacology; 2007 Jan 06; 32(1):43-53. PubMed ID: 16641937
    [Abstract] [Full Text] [Related]

  • 18. Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes.
    Reuben M, Clarke PB.
    Neuropharmacology; 2000 Jan 04; 39(2):290-9. PubMed ID: 10670424
    [Abstract] [Full Text] [Related]

  • 19. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
    Clarke PB, Reuben M, el-Bizri H.
    Br J Pharmacol; 1994 Mar 04; 111(3):695-702. PubMed ID: 8019748
    [Abstract] [Full Text] [Related]

  • 20. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, Vernier JM.
    Brain Res; 2003 Aug 15; 981(1-2):85-98. PubMed ID: 12885429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.